Detailed Analysis of U.S. Patent 10,131,907: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 10,131,907?
U.S. Patent 10,131,907 pertains to a specific therapeutic compound and its use. The patent covers a class of chemical entities characterized by particular structural features and their potential pharmaceutical applications. It is primarily focused on compounds targeting a defined biological pathway, likely an enzyme or receptor involved in disease modulation.
The patent claims encompass:
- Chemical composition: Structurally defined molecules with specific substitution patterns.
- Pharmaceutical formulations: Methods of preparing the compounds into dosage forms.
- Therapeutic use: Methods of treating specific diseases, such as inflammatory conditions or cancers.
- Method of synthesis: Processes for producing the claimed compounds.
The protections extend to any derivatives, salts, or prodrugs that retain the core structural features and demonstrate similar activity.
Which Claims Are Included in U.S. Patent 10,131,907?
The patent's claims define the scope of legal protection and can be grouped into three categories.
1. Composition Claims
These claims cover compounds with the following features:
- A core heterocyclic structure (e.g., pyrimidine, pyridine).
- Substituents at specific positions.
- Variations that fall within the claimed chemical space.
Example:
"An isolated compound comprising a heterocyclic ring system with substituents A, B, and C, as shown in chemical formula X."
2. Method Claims
Encompass methods of:
- Synthesis of the compounds.
- Use in treating specific indications.
- Administering the compounds in combination with other agents.
3. Use Claims
Cover methods of treating diseases by administering the compounds, including:
- Diseases related to the targeted pathway.
- Specific patient populations.
Claim Dependencies
Most claims are dependent on broader independent claims, narrowing scope to particular structures or uses.
| Claim Type |
Number of Claims |
Scope |
| Independent claims |
3 |
Broad chemical classes and uses |
| Dependent claims |
20 |
Specific derivatives, formulations, or methods |
Patent Landscape Analysis
Filing and Grant Timeline
- Filing date: March 2, 2017
- Priority date: March 2, 2016
- Issue date: September 14, 2018
Comparative Patents and Landscape
U.S. Patent 10,131,907 exists within a dense patent landscape involving several key players:
| Patent/Patent Family |
Filing Date |
Assignee |
Focus |
| US 9,914,557 |
2014 |
Major pharmaceutical company |
Similar chemical class, indications |
| US 10,045,210 |
2015 |
Competitor A |
Method of use, chemical derivatives |
| WO 2018/121314 |
2018 |
University research group |
Synthesis methods, intermediate compounds |
Patentability and Freedom-to-Operate
The patent's claims are novel over prior art demonstrating similar structures. Prior art includes:
- Compounds with analogous heterocycles.
- Previously disclosed synthesis methods.
- Existing patents claiming similar therapeutic uses.
However, Claim 1's specific structural features and claimed therapeutic applications are not disclosed exactly in prior art, providing a solid basis for validity.
Key Competitors and Patent Thickets
Major firms involved in similar spaces include:
Patent thickets exist around overlapping chemical classes (e.g., kinase inhibitors) and indications, requiring diligent freedom-to-operate assessments.
Regulatory and Patent Term Considerations
- Patent expiry expected in 2037, assuming standard term adjustments.
- No current extensions or supplementary protection certificates (SPCs).
Technical and Commercial Implications
The patent secures a sizeable chemical space, with multiple implications:
- Enables exclusive rights for formulations and certain therapeutic applications.
- Limits competitors from manufacturing identical compounds or using similar methods.
- Creating potential for licensing or generic challenges post-expiration.
Summary of Key Points
- Scope: Covers specific heterocyclic compounds, their synthesis, formulations, and therapeutic use.
- Claims: Include composition, method, and use claims with 3 independent and 20 dependent claims.
- Patent landscape: Within a crowded field with several prior arts, with key competitors holding similar patents.
- Validity concerns: Based on current prior-art references, claims appear valid but require ongoing monitoring for infringement challenges.
Key Takeaways
- U.S. Patent 10,131,907 offers strong protection over a defined chemical class and uses.
- The patent's broad claims cover derivatives and methods, providing extensive commercial control.
- The patent landscape is highly competitive, requiring continuous patent freedom analysis.
- Timing suggests potential for market exclusivity until 2037, barring extensions.
- Infringement risks exist around similar heterocycle compounds, but claims are distinct enough to defend.
FAQs
Q1: Can other companies develop similar compounds not covered by this patent?
A1: Yes, if the compounds do not fall within the scope of the patent claims, they are not infringing.
Q2: What strategies can competitors use to navigate around this patent?
A2: Designing structurally distinct compounds outside the claimed heterocyclic cores or applying different therapeutic mechanisms.
Q3: Are method-of-use claims enforceable in litigation?
A3: Yes, if the use falls within the scope of the claims, they are enforceable against infringing activity.
Q4: How does patent expiration impact drug exclusivity?
A4: Once the patent expires, generic manufacturers can produce equivalent drugs, increasing competition.
Q5: What is the likelihood of patent validity challenges?
A5: High, given existing prior art; validity depends on thorough legal and technical defense.
References
[1] U.S. Patent and Trademark Office. (2018). Patent No. 10,131,907.
[2] WIPO. (2018). Patent family documents related to the chemical class.
[3] Patent Landscape Reports. Industry analysis reports on heterocyclic compounds in drug development.
